hamburger-icon INVESTORS INVESTMENT CASE Investors At a Glance Financial Highlights Investment Case Business Model Our Strategy CEO Q&A Share Tools Results, Reports and Presentations Financial Calendar Regulatory News Shareholder Services Corporate Governance Investor Contacts Sustainability Newsroom WE’RE THE TRUSTED GLOBAL LEADER IN ACCESS TO MEDICINES In becoming the trusted global leader in access to medicines, the Group has consistently delivered healthy financial returns. We believe there are several reasons to invest in Clinigen. Unique and focused business model Disciplined corporate and product acquisitions Global capability Experienced management team Market-leading positions Broad client and customer base Significant long-term growth potential Cash generative RELATED LINKS ANNUAL REPORT ANNUAL REPORT 2021 Download report (pdf 4.64mb) INVESTORS FINANCIAL HIGHLIGHTS View INVESTORS INVESTMENT CASE Read more OUR GLOBAL OFFICES United Kingdom Europe Asia, Pacific and Japan South Africa United States SITE TOOLS Stay In Touch AE Reporting Medical enquiries Terms of use Cookies Privacy policy Privacy Statement for Pharmacovigilance Data UK Gender Pay Gap Report Modern Slavery Statement Access Online Sitemap Consumer Information Obligations Clinigen Terms And Conditions Of Business (Sales) Clinigen Terms And Conditions Of Business (Purchases) Cookie settings FIND A MEDICINE Online services for healthcare professionals Hard to find medicines (Clinigen Direct) Managed Access Programs (Cliniport) Clinigen Products Twitter Linkedin © Copyright 2021 Clinigen Group plc. By Emperor OUR USE OF COOKIES We use cookies to improve your experience. By clicking accept, we will set recommended analytics cookies. AcceptRejectSettings